R
Rui Wang
Researcher at Lanzhou University
Publications - 343
Citations - 8542
Rui Wang is an academic researcher from Lanzhou University. The author has contributed to research in topics: Enantioselective synthesis & Catalysis. The author has an hindex of 43, co-authored 309 publications receiving 6802 citations. Previous affiliations of Rui Wang include Hong Kong Polytechnic University & University of New Mexico.
Papers
More filters
Journal ArticleDOI
Epitaxial Heterogeneous Interfaces on N-NiMoO4/NiS2 Nanowires/Nanosheets to Boost Hydrogen and Oxygen Production for Overall Water Splitting
TL;DR: In this paper, the oxide/sulfide heterostructures (N-NiMoO4/NiS2 nanowires/nanosheets) were constructed as a multisite HER/OER catalyst.
Journal ArticleDOI
A unique approach to the concise synthesis of highly optically active spirooxazolines and the discovery of a more potent oxindole-type phytoalexin analogue
TL;DR: Preliminary biological evaluation of several of the spirooxazolines using a model of acute neuroinflammation revealed promising antipyretic activity and provided an opportunity to discover new antipYretic agents.
Journal ArticleDOI
Heterostructure-Promoted Oxygen Electrocatalysis Enables Rechargeable Zinc-Air Battery with Neutral Aqueous Electrolyte.
Li An,Zhiyong Zhang,Jianrui Feng,Fan Lv,Yuxuan Li,Rui Wang,Min Lu,Ram B. Gupta,Pinxian Xi,Sen Zhang +9 more
TL;DR: In this paper, the authors reported the controlled synthesis of NiFe2O4/FeNi2S4 heterostructured nanosheets (HNSs) that are highly efficient in catalyzing OER and ORR, therefore enabling neutral rechargeable ZABs.
Journal ArticleDOI
Catalytic Asymmetric Activation of a C sp 3H Bond Adjacent to a Nitrogen Atom: A Versatile Approach to Optically Active α‐Alkyl α‐Amino Acids and C1‐Alkylated Tetrahydroisoquinoline Derivatives
Journal ArticleDOI
Therapeutic peptides: current applications and future directions
TL;DR: This review summarizes the efforts and achievements in peptide drug discovery, production, and modification, and their current applications and discusses the value and challenges associated with future developments in therapeutic peptides.